Hisato Takagi, Takuya Umemoto. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Administration, OralAgedAtorvastatinAtrial Fibrillation/bloodAtrial Fibrillation/etiologyAtrial Fibrillation/prevention & controlBiomarkers/bloodC-Reactive Protein/metabolismCoronary Artery Bypass, Off-Pump/adverse effectsDouble-Blind MethodDrug Administration ScheduleElective Surgical ProceduresFemaleHeptanoic Acids/administration & dosageHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosageKaplan-Meier EstimateLogistic ModelsMaleMiddle AgedOdds RatioPreoperative CarePyrroles/administration & dosageRisk AssessmentRisk FactorsTime FactorsTreatment Outcome
Substances： See more » BiomarkersHeptanoic AcidsHydroxymethylglutaryl-CoA Reductase InhibitorsPyrrolesC-Reactive ProteinAtorvastatin
Year: 2010 PMID： 20921813 DOI： 10.1253/circj.cj-10-0707
Source DB: PubMed Journal: Circ J ISSN： 1346-9843 Impact factor: 2.993